<p>隨着全球市場面臨對人工智能估值和經濟不確定性的擔憂，亞洲市場也未能倖免於這些挑戰，在投資者謹慎的氛圍中經歷了波動。在這種情況下，亞洲那些內部持股比例較高的成長型公司尤其引人注目，因為它們通常表明管理層與股東之間存在強烈的內部信心和利益一致性。</p>
<h3>亞洲內部持股比例高的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>老鋪黃金 (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>富臨精工 (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們關於內部持股比例高的快速成長亞洲公司的 637 只股票的完整列表。</p>
<p>我們將從我們的篩選結果中選取一些進行分析。</p>
<h2>北京新諾藥業研究 (SHSE:688621)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 北京新諾藥業研究有限公司是一家專注於中國藥物研發的合同研究公司，市值為 74.9 億人民幣。</p>
<p><strong>運營：</strong> 北京新諾藥業研究有限公司作為合同研究組織，專注於中國的藥物研發。</p>
<p><strong>內部持股比例：</strong> 35.3%</p>
<p><strong>收入增長預測：</strong> 每年 21.7%。</p>
<p>北京新諾藥業研究顯示出強勁的增長潛力，預計收益將以每年 33.02% 的速度增長，超過中國市場的 27.6%。儘管利潤率從 19.1% 下降至 13.1%，但收入預計將以每年 21.7% 的速度增長，超過市場平均水平。公司的股本回報率預計將達到 24.2% 的高位，而其市盈率為 56.3 倍，低於行業標準，表明該行業相對具有價值。</p>
<ul>
<li>解鎖我們對北京新諾藥業研究股票分析的全面見解，詳見本增長報告。</li>
<li>根據我們最近的估值報告，北京新諾藥業研究的交易價格似乎超出了其估計價值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 SHSE:688621 持股結構</p>
<h2>POCO Holding (SZSE:300811)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> POCO Holding Co., Ltd. 專注於開發、生產和銷售用於電子設備的合金軟磁粉和組件，市值為 220 億人民幣。</p>
<p><strong>運營：</strong> POCO Holding Co., Ltd. 的收入來自於合金軟磁粉、合金軟磁芯和電子設備用户的芯片電感組件的開發、生產和銷售。</p>
<p><strong>內部持股比例：</strong> 24%</p>
<p><strong>收入增長預測：</strong> 每年 24.8%。</p>
<p>POCO Holding 展示出強勁的增長前景，預計收益將以每年 29.7% 的速度增長，超過中國市場的 27.6%。預計收入將以每年 24.8% 的速度增長，超過市場平均水平 14.4%。儘管最近股價波動，但公司在 2025 年前九個月的收入為 13 億人民幣，較去年增加了 0.3 億人民幣，表明其財務表現穩步提升。</p>
<ul>
<li>通過閲讀我們的分析師估計報告，深入瞭解 POCO Holding 的表現。</li>
<li>根據我們的估值報告，POCO Holding 的股價可能偏高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 SZSE:300811 持股結構</p>
<h2>Silergy (TWSE:6415)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Silergy Corp. 設計、製造和銷售集成電路產品及相關技術服務，業務覆蓋中國及國際市場，市值為 791.2 億新台幣。</p>
<p><strong>運營：</strong> 該公司主要通過其半導體部門產生收入，金額為 185.3 億新台幣。</p>
<p><strong>內部持股比例：</strong> 14.2%</p>
<p><strong>收入增長預測：</strong> 每年 15.5%。</p>
<p>Silergy 的增長軌跡穩健，預計收益將以每年 33.71% 的速度增長，超過台灣市場 20.2% 的預測。儘管第三季度銷售和淨收入較去年略有下降，但九個月的數據顯示淨收入從 13.91 億新台幣增加至 16.69 億新台幣。Silergy 的交易價格顯著低於其估計公允價值，並且近期缺乏內部交易活動，仍然是亞洲增長領域一個引人注目的投資機會。</p>
<ul>
<li>點擊探索我們在 Silergy 收益增長報告中的詳細發現。</li>
<li>我們的估值報告顯示 Silergy 可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown"/></p>
<p>截至 2025 年 11 月的 TWSE:6415 持股結構</p>
<h2>總結</h2>
<ul>
<li>在這裏調查我們完整的 637 家快速成長的亞洲公司名單，這些公司內部持股比例高。</li>
<li>對其他可能性感興趣？特朗普的石油繁榮已經到來——管道準備獲利。發現 22 只美國股票正在乘風破浪。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論僅基於歷史數據和分析師預測，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接擁有的股票。所有引用的預測收入和盈利增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>

Universal技術學院

富臨精工

老鋪黃金

<p>這篇文章強調了亞洲一些內部持股比例高的成長型公司，表明內部信心強烈。主要公司包括 UTI、Streamax Technology、Seers Technology、Novoray、Loadstar Capital、老鋪黃金、J&V Energy Technology、Gold Circuit Electronics、富臨精工和 Bora Pharmaceuticals。文章對北京陽諾藥業研究、POCO Holding 和 Silergy 進行了詳細分析，展示了它們的成長潛力和財務表現。文章強調了內部持股在管理層與股東利益對齊中的重要性</p>

<p>As global markets grapple with concerns over AI valuations and economic uncertainties, the Asian market has not been immune to these challenges, experiencing fluctuations amid investor caution. In this climate, growth companies in Asia with high insider ownership are particularly intriguing as they often indicate strong internal confidence and alignment of interests between management and shareholders.</p>
<div class="lb-trans"><p>隨着全球市場面臨對人工智能估值和經濟不確定性的擔憂，亞洲市場也未能倖免於這些挑戰，在投資者謹慎的氛圍中經歷了波動。在這種情況下，亞洲那些內部持股比例較高的成長型公司尤其引人注目，因為它們通常表明管理層與股東之間存在強烈的內部信心和利益一致性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亞洲內部持股比例高的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25.2%</td>
<td>110.4%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>老鋪黃金 (SEHK:6181)</td>
<td>34.8%</td>
<td>34.3%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>32.6%</td>
</tr>
<tr>
<td>富臨精工 (SZSE:300432)</td>
<td>11.6%</td>
<td>55.2%</td>
</tr>
<tr>
<td>Bora Pharmaceuticals (TWSE:6472)</td>
<td>11.9%</td>
<td>20.3%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 637 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們關於內部持股比例高的快速成長亞洲公司的 637 只股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我們將從我們的篩選結果中選取一些進行分析。</p>
</div><h2>Beijing Sun-Novo Pharmaceutical Research (SHSE:688621)</h2>
<div class="lb-trans"><h2>北京新諾藥業研究 (SHSE:688621)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥7.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京新諾藥業研究有限公司是一家專注於中國藥物研發的合同研究公司，市值為 74.9 億人民幣。</p>
</div><p><strong>Operations:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. specializes in drug research and development as a contract research organization in China.</p>
<div class="lb-trans"><p><strong>運營：</strong> 北京新諾藥業研究有限公司作為合同研究組織，專注於中國的藥物研發。</p>
</div><p><strong>Insider Ownership:</strong> 35.3%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 35.3%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 21.7% p.a.</p>
<div class="lb-trans"><p><strong>收入增長預測：</strong> 每年 21.7%。</p>
</div><p>Beijing Sun-Novo Pharmaceutical Research shows strong growth potential, with earnings expected to increase by 33.02% annually, outpacing the Chinese market's 27.6%. Despite a decline in profit margins from 19.1% to 13.1%, revenue is forecasted to grow at a robust 21.7% per year, surpassing market averages. The company’s Return on Equity is projected to reach a high of 24.2%, while its P/E ratio of 56.3x remains below industry norms, suggesting relative value in the sector.</p>
<div class="lb-trans"><p>北京新諾藥業研究顯示出強勁的增長潛力，預計收益將以每年 33.02% 的速度增長，超過中國市場的 27.6%。儘管利潤率從 19.1% 下降至 13.1%，但收入預計將以每年 21.7% 的速度增長，超過市場平均水平。公司的股本回報率預計將達到 24.2% 的高位，而其市盈率為 56.3 倍，低於行業標準，表明該行業相對具有價值。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Beijing Sun-Novo Pharmaceutical Research stock in this growth report.</li>
<li>In light of our recent valuation report, it seems possible that Beijing Sun-Novo Pharmaceutical Research is trading beyond its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對北京新諾藥業研究股票分析的全面見解，詳見本增長報告。</li>
<li>根據我們最近的估值報告，北京新諾藥業研究的交易價格似乎超出了其估計價值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown"/></p>
<p>SHSE:688621 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 SHSE:688621 持股結構</p>
</div><h2>POCO Holding (SZSE:300811)</h2>
<div class="lb-trans"><h2>POCO Holding (SZSE:300811)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> POCO Holding Co., Ltd. specializes in developing, producing, and selling alloy soft magnetic powder and components for electronic equipment, with a market cap of CN¥22 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> POCO Holding Co., Ltd. 專注於開發、生產和銷售用於電子設備的合金軟磁粉和組件，市值為 220 億人民幣。</p>
</div><p><strong>Operations:</strong> POCO Holding Co., Ltd. generates revenue from the development, production, and sale of alloy soft magnetic powder, alloy soft magnetic cores, and chip inductance components for electronic equipment users.</p>
<div class="lb-trans"><p><strong>運營：</strong> POCO Holding Co., Ltd. 的收入來自於合金軟磁粉、合金軟磁芯和電子設備用户的芯片電感組件的開發、生產和銷售。</p>
</div><p><strong>Insider Ownership:</strong> 24%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 24%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 24.8% p.a.</p>
<div class="lb-trans"><p><strong>收入增長預測：</strong> 每年 24.8%。</p>
</div><p>POCO Holding demonstrates strong growth prospects with earnings expected to grow at 29.7% annually, surpassing the Chinese market's 27.6%. Revenue is forecasted to increase by 24.8% per year, outpacing the market average of 14.4%. Despite a volatile share price recently, the company reported CNY 1.3 billion in revenue for the first nine months of 2025, up from CNY 1.23 billion last year, indicating steady progress in its financial performance.</p>
<div class="lb-trans"><p>POCO Holding 展示出強勁的增長前景，預計收益將以每年 29.7% 的速度增長，超過中國市場的 27.6%。預計收入將以每年 24.8% 的速度增長，超過市場平均水平 14.4%。儘管最近股價波動，但公司在 2025 年前九個月的收入為 13 億人民幣，較去年增加了 0.3 億人民幣，表明其財務表現穩步提升。</p>
</div><ul>
<li>Get an in-depth perspective on POCO Holding's performance by reading our analyst estimates report here.</li>
<li>According our valuation report, there's an indication that POCO Holding's share price might be on the expensive side.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過閲讀我們的分析師估計報告，深入瞭解 POCO Holding 的表現。</li>
<li>根據我們的估值報告，POCO Holding 的股價可能偏高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown"/></p>
<p>SZSE:300811 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 SZSE:300811 持股結構</p>
</div><h2>Silergy (TWSE:6415)</h2>
<div class="lb-trans"><h2>Silergy (TWSE:6415)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Silergy Corp. designs, manufactures, and sells integrated circuit products and related technical services both in China and internationally, with a market cap of NT$79.12 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Silergy Corp. 設計、製造和銷售集成電路產品及相關技術服務，業務覆蓋中國及國際市場，市值為 791.2 億新台幣。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its semiconductors segment, amounting to NT$18.53 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司主要通過其半導體部門產生收入，金額為 185.3 億新台幣。</p>
</div><p><strong>Insider Ownership:</strong> 14.2%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 14.2%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 15.5% p.a.</p>
<div class="lb-trans"><p><strong>收入增長預測：</strong> 每年 15.5%。</p>
</div><p>Silergy's growth trajectory is robust, with earnings projected to rise 33.71% annually, outpacing the Taiwanese market's 20.2% forecast. Despite a slight dip in Q3 sales and net income compared to last year, nine-month figures show an increase in net income from TWD 1,391.25 million to TWD 1,668.88 million. Trading at a significant discount to its estimated fair value and lacking recent insider trading activity, Silergy remains an intriguing investment opportunity in Asia's growth sector.</p>
<div class="lb-trans"><p>Silergy 的增長軌跡穩健，預計收益將以每年 33.71% 的速度增長，超過台灣市場 20.2% 的預測。儘管第三季度銷售和淨收入較去年略有下降，但九個月的數據顯示淨收入從 13.91 億新台幣增加至 16.69 億新台幣。Silergy 的交易價格顯著低於其估計公允價值，並且近期缺乏內部交易活動，仍然是亞洲增長領域一個引人注目的投資機會。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Silergy's earnings growth report.</li>
<li>Our valuation report here indicates Silergy may be undervalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊探索我們在 Silergy 收益增長報告中的詳細發現。</li>
<li>我們的估值報告顯示 Silergy 可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown"/></p>
<p>TWSE:6415 Ownership Breakdown as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 TWSE:6415 持股結構</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>總結</h2>
</div><ul>
<li>Investigate our full lineup of 637 Fast Growing Asian Companies With High Insider Ownership right here.</li>
<li>Interested In Other Possibilities? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏調查我們完整的 637 家快速成長的亞洲公司名單，這些公司內部持股比例高。</li>
<li>對其他可能性感興趣？特朗普的石油繁榮已經到來——管道準備獲利。發現 22 只美國股票正在乘風破浪。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論僅基於歷史數據和分析師預測，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接擁有的股票。所有引用的預測收入和盈利增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
</div>

3 家內部持股比例高的亞洲成長型公司值得關注